MHUA
Meihua International Medical Technologies Co., Ltd.
Medical - Instruments & Supplies
Market Cap$2M
5Y Perf.-99.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
MHUA vs DBVT
Revenue, margins, valuation, and 5-year total return — side by side.
DBVT
DBV Technologies S.A.
Biotechnology
Market Cap$1712.35T
5Y Perf.+56.6%
MHUA vs DBVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | MHUA | DBVT |
|---|---|---|
| Industry | Medical - Instruments & Supplies | Biotechnology |
| Market Cap | $2M | $1712.35T |
| Revenue (TTM) | $184M | $0.00 |
| Net Income (TTM) | $19M | $-168M |
| Gross Margin | 33.6% | — |
| Operating Margin | 12.6% | — |
| Forward P/E | 0.2x | — |
| Total Debt | $8M | $22M |
| Cash & Equiv. | $16M | $194M |
MHUA vs DBVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
MHUA
DBVT
| Stock | Feb 22 | Apr 26 | Return |
|---|---|---|---|
| Meihua Internationa… (MHUA) | 100 | 0.9 | -99.1% |
| DBV Technologies S.… (DBVT) | 100 | 156.6 | +56.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MHUA vs DBVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MHUA leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. DBV Technologies S.A. is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
MHUA
Meihua International Medical Technologies Co., Ltd.
The Growth Play
MHUA carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth -0.2%, EPS growth -18.4%, 3Y rev CAGR -2.3%
- Lower volatility, beta 2.86, Low D/E 5.0%, current ratio 5.26x
- -0.2% revenue growth vs DBVT's -100.0%
Best for: growth exposure and sleep-well-at-night
DBVT
DBV Technologies S.A.
The Income Pick
DBVT is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 1.26
- -87.0% 10Y total return vs MHUA's -99.4%
- Beta 1.26, current ratio 3.67x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | MHUA | -0.2% revenue growth vs DBVT's -100.0% |
| Quality / Margins | MHUA | 10.1% margin vs DBVT's 0.3% |
| Stability / Safety | DBVT | Beta 1.26 vs MHUA's 2.86 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | DBVT | +110.4% vs MHUA's -73.6% |
| Efficiency (ROA) | MHUA | 9.7% ROA vs DBVT's -89.0% |
MHUA vs DBVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLDBVTLAGGINGMHUA
MHUAMeihua International …
1leads
DBVTDBV Technologies S.A.
3leads
6 Total Categories
CATEGORYLEADERvs MHUAMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
DBVT1/1
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
MHUA6/7
Total Returns1Y, 3Y, 5Y total returns with dividends
DBVT5/6
Risk & VolatilityBeta, volatility, and downside exposure
DBVT2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
DBVT leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
MHUA and DBVT operate at a comparable scale, with $184M and $0 in trailing revenue.
| Metric | MHUAMeihua Internatio… | DBVTDBV Technologies … |
|---|---|---|
| RevenueTrailing 12 months | $184M | $0 |
| EBITDAEarnings before interest/tax | $24M | -$112M |
| Net IncomeAfter-tax profit | $19M | -$168M |
| Free Cash FlowCash after capex | $12M | -$151M |
| Gross MarginGross profit ÷ Revenue | +33.6% | — |
| Operating MarginEBIT ÷ Revenue | +12.6% | — |
| Net MarginNet income ÷ Revenue | +10.1% | — |
| FCF MarginFCF ÷ Revenue | +6.6% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.2% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -35.8% | +91.5% |
DBVT leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
Evenly matched — MHUA and DBVT each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | MHUAMeihua Internatio… | DBVTDBV Technologies … |
|---|---|---|
| Market CapShares × price | $2M | $1712.35T |
| Enterprise ValueMkt cap + debt − cash | -$6M | $1712.35T |
| Trailing P/EPrice ÷ TTM EPS | 0.19x | -0.76x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | -0.40x | — |
| Price / SalesMarket cap ÷ Revenue | 0.02x | — |
| Price / BookPrice ÷ Book value/share | 0.01x | 0.66x |
| Price / FCFMarket cap ÷ FCF | 0.14x | — |
Evenly matched — MHUA and DBVT each lead in 1 of 2 comparable metrics.
Profitability & Efficiency
MHUA leads this category, winning 6 of 7 comparable metrics.
Profitability & Efficiency
MHUA delivers a 11.2% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-130 for DBVT. MHUA carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to DBVT's 0.13x.
| Metric | MHUAMeihua Internatio… | DBVTDBV Technologies … |
|---|---|---|
| ROE (TTM)Return on equity | +11.2% | -130.2% |
| ROA (TTM)Return on assets | +9.7% | -89.0% |
| ROICReturn on invested capital | +7.4% | — |
| ROCEReturn on capital employed | +9.4% | -145.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.05x | 0.13x |
| Net DebtTotal debt minus cash | -$8M | -$172M |
| Cash & Equiv.Liquid assets | $16M | $194M |
| Total DebtShort + long-term debt | $8M | $22M |
| Interest CoverageEBIT ÷ Interest expense | 31.87x | -189.82x |
MHUA leads this category, winning 6 of 7 comparable metrics.
Total Returns (Dividends Reinvested)
DBVT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DBVT five years ago would be worth $3,090 today (with dividends reinvested), compared to $59 for MHUA. Over the past 12 months, DBVT leads with a +110.4% total return vs MHUA's -73.6%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs MHUA's -71.3% — a key indicator of consistent wealth creation.
| Metric | MHUAMeihua Internatio… | DBVTDBV Technologies … |
|---|---|---|
| YTD ReturnYear-to-date | +271.2% | +4.9% |
| 1-Year ReturnPast 12 months | -73.6% | +110.4% |
| 3-Year ReturnCumulative with dividends | -97.6% | +19.7% |
| 5-Year ReturnCumulative with dividends | -99.4% | -69.1% |
| 10-Year ReturnCumulative with dividends | -99.4% | -87.0% |
| CAGR (3Y)Annualised 3-year return | -71.3% | +6.2% |
DBVT leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
DBVT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DBVT is the less volatile stock with a 1.26 beta — it tends to amplify market swings less than MHUA's 2.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DBVT currently trades 76.3% from its 52-week high vs MHUA's 11.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | MHUAMeihua Internatio… | DBVTDBV Technologies … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.86x | 1.26x |
| 52-Week HighHighest price in past year | $64.00 | $26.18 |
| 52-Week LowLowest price in past year | $2.05 | $7.53 |
| % of 52W HighCurrent price vs 52-week peak | +11.9% | +76.3% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 48.1 |
| Avg Volume (50D)Average daily shares traded | 1K | 252K |
DBVT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | MHUAMeihua Internatio… | DBVTDBV Technologies … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $46.33 |
| # AnalystsCovering analysts | — | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +9.6% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
DBVT leads in 3 of 6 categories (Income & Cash Flow, Total Returns). MHUA leads in 1 (Profitability & Efficiency). 1 tied.
Best OverallDBV Technologies S.A. (DBVT)Leads 3 of 6 categories
Loading custom metrics...
MHUA vs DBVT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is MHUA or DBVT a better buy right now?
Meihua International Medical Technologies Co.
, Ltd. (MHUA) offers the better valuation at 0. 2x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — MHUA or DBVT?
Over the past 5 years, DBV Technologies S.
A. (DBVT) delivered a total return of -69. 1%, compared to -99. 4% for Meihua International Medical Technologies Co. , Ltd. (MHUA). Over 10 years, the gap is even starker: DBVT returned -87. 0% versus MHUA's -99. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — MHUA or DBVT?
By beta (market sensitivity over 5 years), DBV Technologies S.
A. (DBVT) is the lower-risk stock at 1. 26β versus Meihua International Medical Technologies Co. , Ltd. 's 2. 86β — meaning MHUA is approximately 128% more volatile than DBVT relative to the S&P 500. On balance sheet safety, Meihua International Medical Technologies Co. , Ltd. (MHUA) carries a lower debt/equity ratio of 5% versus 13% for DBV Technologies S. A. — giving it more financial flexibility in a downturn.
04Which is growing faster — MHUA or DBVT?
On earnings-per-share growth, the picture is similar: Meihua International Medical Technologies Co.
, Ltd. grew EPS -18. 4% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — MHUA or DBVT?
Meihua International Medical Technologies Co.
, Ltd. (MHUA) is the more profitable company, earning 11. 2% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 11. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MHUA leads at 14. 8% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — MHUA leads at 34. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — MHUA or DBVT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is MHUA or DBVT better for a retirement portfolio?
For long-horizon retirement investors, DBV Technologies S.
A. (DBVT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 26)). Meihua International Medical Technologies Co. , Ltd. (MHUA) carries a higher beta of 2. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DBVT: -87. 0%, MHUA: -99. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between MHUA and DBVT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MHUA is a small-cap deep-value stock; DBVT is a mega-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.